We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $345M
1-Year Est. Return 39.04%
This Fund
S&P 500
This Quarter Est. Return
+21.23%
1 Year Est. Return
+39.04%
3 Year Est. Return
+141.86%
5 Year Est. Return
+190.64%
10 Year Est. Return
AUM
$345M
AUM Growth
+$49.9M
Cap. Flow
-$12.5M
Cap. Flow %
-3.61%
Top 10 Hldgs %
49.65%
Holding
604
New
51
Increased
61
Reduced
127
Closed
28

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.99M
2
AAPL icon
Apple
AAPL
+$1.8M
3
AVGO icon
Broadcom
AVGO
+$1.05M
4
TSM icon
TSMC
TSM
+$761K
5
GTLS
Chart Industries
GTLS
+$755K

Sector Composition

Rank Sector Weight
1 Technology 55.59%
2 Miscellaneous 12.28%
3 Healthcare 7.42%
4 Industrials 5.45%
5 Consumer Staples 5.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALK icon
501
Alaska Air
ALK
$4.69B
$2.03K ﹤0.01%
42
QUAL icon
502
iShares MSCI USA Quality Factor ETF
QUAL
$47.5B
$2.03K ﹤0.01%
9
SOLV icon
503
Solventum
SOLV
$15.6B
$2.02K ﹤0.01%
24
+2
+9% +$146
VIGI icon
504
Vanguard International Dividend Appreciation ETF
VIGI
$9.29B
$1.98K ﹤0.01%
20
RGEN icon
505
Repligen
RGEN
$9.46B
$1.98K ﹤0.01%
12
ARKW icon
506
ARK Web x.0 ETF
ARKW
$1.86B
$1.8K ﹤0.01%
12
VWOB icon
507
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.2B
$1.65K ﹤0.01%
25
REGN icon
508
Regeneron Pharmaceuticals
REGN
$85.2B
$1.59K ﹤0.01%
2
EMLC icon
509
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$5B
$1.59K ﹤0.01%
62
ALB icon
510
Albemarle
ALB
$14.9B
$1.55K ﹤0.01%
+12
New +$2.12K
ALNY icon
511
Alnylam Pharmaceuticals
ALNY
$35.6B
$1.55K ﹤0.01%
7
EVR icon
512
Evercore
EVR
$11.5B
$1.51K ﹤0.01%
5
GEHC icon
513
GE HealthCare
GEHC
$31.1B
$1.46K ﹤0.01%
20
HYLB icon
514
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.51B
$1.45K ﹤0.01%
40
AMD icon
515
Advanced Micro Devices
AMD
$780B
$1.42K ﹤0.01%
+3
New +$1.23K
AWK icon
516
American Water Works
AWK
$28B
$1.36K ﹤0.01%
10
LNTH icon
517
Lantheus
LNTH
$6.59B
$1.31K ﹤0.01%
13
FVD icon
518
First Trust Value Line Dividend Fund
FVD
$8.19B
$1.26K ﹤0.01%
25
XPH icon
519
State Street SPDR S&P Pharmaceuticals ETF
XPH
$571M
$1.26K ﹤0.01%
18
MTUM icon
520
iShares MSCI USA Momentum Factor ETF
MTUM
$24.7B
$1.23K ﹤0.01%
4
DON icon
521
WisdomTree US MidCap Dividend Fund
DON
$4.05B
$1.23K ﹤0.01%
21
VT icon
522
Vanguard Total World Stock ETF
VT
$81.5B
$1.13K ﹤0.01%
7
MPT
523
Medical Properties Trust
MPT
$2.39B
$1K ﹤0.01%
250
EOG icon
524
EOG Resources
EOG
$76.2B
$1K ﹤0.01%
7
+5
+250% +$681
TAK icon
525
Takeda Pharmaceutical
TAK
$58.9B
$996 ﹤0.01%
57

Similar funds

Front Row Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Front Row Advisors held 604 positions worth $345M, up 17% from $296M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Front Row Advisors withdrew a net $12.5M in Q2 2026, closing 28 positions and reducing 127 holdings. Its most notable exit was Chart Industries, an estimated $755K position sold in full.

By sector, the portfolio is most concentrated in Technology at 56% of assets, up from 52% a quarter earlier, followed by Miscellaneous and Healthcare.

Against the trend, Front Row Advisors opened a new position in Honeywell Aerospace worth $502K.

  • Front Row Advisors's largest Q2 2026 buy was Honeywell Aerospace: 3,023 shares worth $502K.
  • Front Row Advisors added most to Nebius Group N.V. in Q2 2026, an estimated $277K increase.
  • Front Row Advisors's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.99M.
  • Front Row Advisors fully exited Chart Industries in Q2 2026, selling an estimated $755K.
  • Front Row Advisors's ten largest holdings make up 50% of its $345M portfolio in Q2 2026.
  • Front Row Advisors opened 51 new positions and closed 28 in Q2 2026.
  • Front Row Advisors's portfolio value rose 17% quarter-over-quarter to $345M.

Based on Front Row Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.